Is It Possible to Screen for Primary Aldosteronism Effectively in Primary Care?
Open Access
- 7 April 2025
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 103 (2) , 129-136
Abstract
Objective: Primary aldosteronism (PA) is the commonest secondary cause of hypertension but case‐detection remains a challenge. Screening is usually performed in secondary care using an aldosterone:renin ratio (ARR) measurement. Here, we describe the outcomes of screening in primary care, in Oxfordshire, UK.Design: Retrospective observational study.Patients: Adults screened for PA in primary care services in Oxford between 2008 and 2022.Measurements: ARR test results in primary care and outcomes of secondary care evaluation (ARR, saline infusion test, final diagnosis). Primary care and secondary care ARR tests were compared for correlation, concordance and performance in predicting PA.Results: Among 2915 adults screened in primary care, 455 were referred to secondary care and 107 (3.7% of total population screened) were diagnosed with PA. Primary care ARR showed strong correlation with secondary care ARR (r = 0.841, p < 0.001). Area under the ROC curve to predict PA was 0.81 (95% CI 0.77–0.86) for primary care ARR testing. Primary care ARR cut‐off of ≥ 30 pmol/mU showed comparable sensitivity (91.7% vs 92.1%, p = 0.467) to and modest concordance (Kappa 0.583, p < 0.001) with secondary care ARR. Use of beta‐blockers were associated with higher risk of false positive test result (OR 3.5, 95% CI 1.1–12.0, p = 0.042).Conclusions: Screening for PA in primary care with ARR is feasible with modest concordance and comparable sensitivity to secondary care testing. Simple referral criteria and raising awareness among primary care colleagues could ensure appropriate referral to secondary care.Keywords
This publication has 22 references indexed in Scilit:
- 2024 ESC Guidelines for the management of elevated blood pressure and hypertensionEuropean Heart Journal, 2024
- Development of diagnostic algorithm for Cushing’s syndrome: a tertiary centre experienceJournal of Endocrinological Investigation, 2024
- Primary Aldosteronism: State-of-the-Art ReviewAmerican Journal of Hypertension, 2022
- ‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronismBMJ Open, 2022
- Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary careEndocrine, 2022
- Primary aldosteronismTrends in Cardiovascular Medicine, 2022
- Outcomes of a Specialized Clinic on Rates of Investigation and Treatment of Primary AldosteronismJAMA Surgery, 2021
- Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort studyThe Lancet Diabetes & Endocrinology, 2018
- Screening for primary aldosteronism using the newly developed IDS-iSYS® automated assay systemPractical Laboratory Medicine, 2017
- Evidence for an increased rate of cardiovascular events in patients with primary aldosteronismJACC, 2005